American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update
No abstract is available. To read the body of this article, please view the Full Text online.
⁎Associate Professor, Division of Oral and Maxillofacial Surgery, Stony Brook School of Dental Medicine; Attending, Long Island Jewish Medical Center, New Hyde Park, NY; New York Center for Orthognathic and Maxillofacial Surgery, Lake Success, NY
†Visiting Oral and Maxillofacial Surgeon and Director, Center for Applied Clinical Investigation, Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital; Associate Professor, Harvard School of Dental Medicine, Boston, MA
‡Professor and Chairman, Oral and Maxillofacial Surgery, Oregon Health and Science University, Portland, OR
§Associate Professor, Division Oral Maxillofacial Surgery, Columbia University School of Dental and Oral Surgery, New York, NY
¶Professor of Surgery and Chief, Division of Oral and Maxillofacial Surgery, University of Miami School of Medicine, Miami, FL
∥Section Head, Division of Medical Oncology, Long Island Jewish Medical Center, and Associate Professor of Clinical Medicine, Albert Einstein College of Medicine, New Hyde Park, NY
Address correspondence and reprint requests to Dr Ruggiero: Division of Oral and Maxillofacial Surgery, Stony Brook School of Dental Medicine, Long Island Jewish Medical Center, New Hyde Park, NY; New York Center for Orthognathic and Maxillofacial Surgery, 2001 Marcus Avenue, Lake Success, NY 11042
Approved by the Board of Trustees January 2009.
Dr Ruggiero is a paid consultant for Amgen Corporation and Procter and Gamble and has received honorarium from Novartis; Dr Dodson states no financial arrangements or affiliations with a corporate organization or a manufacturer of products discussed in this article; Dr Assael is a paid consultant for Novartis and has received honoraria from Novartis and Merck; Dr Landesberg has received honoraria from Novartis Pharmaceutical Corporation; Dr Marx is a paid consultant for Medtronics and is a shareholder for Harvest Technologies. He receives royalties from Quintessence Publishing. Stryker, Synthes Maxillofacial, Biomet 3i, and Biomet Microfixation provide residency support at the Miami School of Medicine, although Dr Marx receives no personal monies from this funding. Dr Marx is a voluntary unpaid expert witness for Osborn LLC attorneys in litigation against Novartis Pharmaceuticals and Merck Co. Dr Mehrotra served as a consultant and on the Advisory Board and Speaker's Bureau for Novartis Pharmaceuticals.
